🔎 Trials Near Me

Pradžia › Išsėtinė sklerozė › Masčusetsas

Išsėtinė sklerozė klinikiniai tyrimai Masčusetsas

18 tyrimai dėl Išsėtinė sklerozė ieško dalyvių vietose Masčusetsas.

Miestai Masčusetsas

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Neurology Center of New England, Foxborough
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06782490

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Boston
  • TG Therapeutics Investigational Trial Site, Burlington
  • TG Therapeutics Investigational Trial Site, Norfolk
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Dana Farber Cancer Institute, Boston
  • University of Massachusetts Chan Medical Center, Worcester
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07002034

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Neuro Institute of New England P C, Foxborough
  • Elliot Lewis MS Center, Wellesley
  • U Mass Memorial Medical Center, Worchester
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT07225504

Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis

  • MGH Institute of Health Professions, Boston
Renkami dalyviai3 fazė
Amžius nuo 25 iki 75 · Visoms lytims · Atnaujinta 2026-07-20 · NCT06136728

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

  • Beth Israel Deaconess Medical Center, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-11 · NCT04603196

Care in Multiple Sclerosis (MS)

  • Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-05 · NCT07011914

Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • Brigham MS Center, 60 Fenwood Road, Boston
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-02-02 · NCT03207464

PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

  • Brigham MS Center, 60 Fenwood Road, Boston
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-01-28 · NCT02649985

Glucose Consumption in MS Using [F-18]FDG-PET

  • Brigham & Women's Hospital, Boston
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-01-09 · NCT07087106

Assessment of Synaptic Density in MS

  • Brigham and Women's Hospital, Boston
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-01-09 · NCT04634994

Efgartigimod for the Treatment of Acute Optic Neuritis

  • Massachusetts Eye and Ear Infirmary, Boston
  • Massachusetts General Hospital, Boston
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-10 · NCT06453694

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

  • UMass Boston, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-08-22 · NCT06554340

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

  • Brigham and Women's Hospital, Boston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-06-06 · NCT06890923

Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

  • Massachusetts General Hospital, Boston
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-02-27 · NCT04699747

IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis

  • Accelerated Cure Project, Waltham
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2025-02-18 · NCT02486562

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

  • Neurology Center of New England P.C., Foxborough
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 55 iki 80 · Visoms lytims · Atnaujinta 2024-11-18 · NCT06681623

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.